A distinct basic fibroblast growth factor (FGF-2)/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells

Molecular Biology of the Cell

Volumn 7, Issue 3, 1996, Pages 369-381

  Rusnati, Marco ^a   Dell'Era, Patrizia ^a   Urbinati, Chiara ^a   Tanghetti, Elena ^a   Massardi, Maria Luisa ^a   Nagamine, Yoshikuni ^b   Monti, Eugenio ^a   Presta, Marco ^a,c  

^a UNIVERSITY OF BRESCIA   (Italy)

^b FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^c General Pathology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2 [112-155]; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR BLOCKING AGENT; HEPARIN; PROTAMINE; SURAMIN; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; UROKINASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CATTLE; CELL PROLIFERATION; ENDOTHELIUM CELL; FETUS; MITOGENESIS; NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; QUANTITATIVE DIAGNOSIS; RECEPTOR BLOCKING; RECEPTOR UPREGULATION;

EID: 0029876408     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.7.3.369     Document Type: Article

References (63)

1. Akiyama, T., Ishida, J , Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M., and Fukami, Y. (1987). Genistein, a specific inhibitor of tyrosine-specitic protein kinases. J Biol Chem. 262, 5592-5595.
2. Baird, A., Schubert, D., Ling, N., and Guillemin, R. (1988). Receptor-and heparin-binding domains of basic fibroblast growth factor. Proc. Natl. Acad. Sci. USA 85, 2324-2328.
3. Basilico, C., and Moscatelli, D. (1992). The FGF family of growth factors and oncogenes. Adv. Cancer Res. 59, 115-165.
4. Bergonzoni, L., Caccia, P., Cletini, O., Sarmientos, P , and Isacchi, A. (1992). Characterization of a biologically active extracellular domain of the FGF Receptor-1 expressed in Escherichia coli. Eur. J. Biochem. 210, 823-829.
5. Besser, D., Presta, M., and Nagamine, Y. (1995). Elucidation of a signalling pathway induced by FGF-2 leading to uPA gene expression in NIH 3T3 fibroblasts. Cell Growth Differ. 6, 1009-1017.
6. Bikfalvi, A., Klein, S., Pintucci, G., Quarto, N., Mignatti, P., and Rifkin, D.B. (1995). Differential modulation of cell phenotype by different molecular weight forms of basic fibroblast growth factor: possible intracellular signalling by the high molecular weight forms. J. Cell Biol. 129, 233-243.
7. 1 transition. Proc. Natl. Acad. Sci. USA 84, 6770-6774.
8. Boyer, B., and Thiery, J.P. (1993). Cyclic AMP distinguishes between two functions of acidic FGF in a rat bladder carcinoma cell line. J. Cell Biol. 120, 767-776.
9. Chellaiah, A.T., McEwen, D.G., Werner, S., Xu, J., and Ornitz, D.M. (1994). Fibroblast growth factor receptor (FGFR) 3. J. Biol. Chem. 269, 11620-11627.
10. Chen, P., Gupta, K., and Wells, A. (1994). Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis. J. Cell Biol. 124, 547-555.
11. Claesson-Welsh, L. (1994). Platelet-derived growth factor receptor signals. J. Biol. Chem. 269, 32023-32026.
12. Coltrini, D., Gualandris, A., Nelli, E.E., Parolini, S., Molinari-Tosatti, M.P., Quarto, N., Ziehe, M., Giavazzi, R., and Presta, M. (1995). Growth advantage and vascularization induced by basic fibroblast growth factor overexpression in endometrial HEC-1-B cells: an export-dependent mechanism of action. Cancer Res. 55, 4729-4738.
13. Debs, R.J., Dzgnes, N., Brunette, E.N., Fendly, B., Patton, J., and Philip, R. (1989). Liposome-associated tumor necrosis factor retains bioactivity in the presence of neutralizing anti-rumor necrosis factor antibodies. J. Immunol. 143, 1192-1197.
14. Dell'Era, P., Presta, M., and Ragnotti, G. (1991). Nuclear localization of endogenous basic fibroblast growth factor in cultured endothelial cells. Exp. Cell Res. 192, 505-510.
15. Dionne, C.A., Crumley, G., Bellot, F., Kaplow, J.M., Sersoss, G., Ruta, M., Burgess, W.H., Jaye, M., and Schlessinger, J. (1990) Cloning and expression of distinct high affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J. 9, 2685-2692.
16. Fidler, I.J., Fogler, W.E., Kleinerman, E.G., and Saiki, I. (1985). Abrogation of species specificity of activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-γ encapsulated in liposomes. J. Immunol. 135, 4289-4296.
17. Fujimon, A., Cheng, S.-L., Avioli, L.V., and Civitelli, R. (1991). Dissociation of second messenger activation by parathyroid hormone fragments in osteosarcoma cells. Endocrinology 128, 3032-3039.
18. Gazit, A., Yaish, P., Gilon, C., and Levitzki, A. (1989). Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors. J. Med. Chem. 32, 2344-2352.
19. Gherardi, E., and Stoker, M. (1991). Hepatocyte growth factor/ scatter factor: mitogen, motogen and MET. Cancer Cells 31, 227-232.
20. Grinspan, J.B., Stephen, N.M., and Levine, E.M. (1983). Bovine endothelial cells transformed in vitro with benzo(a)pyrene. J. Cell. Physiol 114, 328-338.
21. Gualandris, A , and Presta, M. (1995). Transcriptional and posttranscriptional regulation of urokinase-type plasminogen activator expression in endothelial cells by basic fibroblast growth factor. J. Cell. Physiol. 162, 400-409.
22. Isacchi, A., Staruto, M., Chiesa, R., Bergonzoni, L., Rusnati, M., Sarmientos, P., Ragnotti, G., and Presta, M. (1991). A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity. Proc. Natl. Acad. Sci. USA 88, 2628-2632.
23. Johnson, D.E., Lu, J., Chen, H., Werner, S., and Williams, L.T (1991). The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain. Mol. Cell. Biol. 11, 4627-4634.
24. Johnson, D E., and Williams, L.T. (1993). Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 60, 1-41.
25. Katsuura, M., and Tanaka, S. (1989). Topographic analysis of human epidermal growth factor by monospecific antibodies and synthetic peptides. J. Biochem. 106, 87-92.
26. Keegan, K., Johnson, D.E., Williams, L.T., and Hayman, M.J. (1991). Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. Proc. Natl. Acad. Sci. USA 88, 1095-1099.
27. Kern, F.G., and Basilico, C. (1985). Transcription from the polyoma late promoter in cells stably transformed by chimeric plasmids. Mol. Cell. Biol. 5, 797-807.
28. Klein, S., Giancotti, F., Presta, M., Albelda, S.M., Buck, C.A., and Rifkin, D.B. (1993). Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells Mol. Biol. Cell 4, 973-982.
29. Lee, P.L., Johnson, D.E., Cousens, L.S., Frerto, L.J., and Williams, L.T. (1989). Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. Science 245, 57-60.
30. Li, Y., Basilico, C., and Mansukhani, A. (1994). Cell transformation by fibroblast growth factors can be suppressed by truncated fibroblast growth factor receptors. Mol. Cell. Biol. 14, 7660-7669.
31. Lokker, N.A., Mark, M.R., Luis, E.A., Bennett, G.L., Robbins, K.A., Baker, J.B., and Godowski, P.J. (1992). Structure-function analysis of hepatocyte growth factor: identification of variants that lack mitogenic activity yet retain high affinity receptor binding. EMBO J. 11, 2503-2510.
32. Maher, P.A. (1993). Inhibition of the tyrosine kinase activity of the fibroblast growth factor receptor by the methyltransferase inhibitor 5′-methylthioadenosine. J. Biol. Chem. 268, 4244-4249.
33. Marshall, C.J. (1995). Specificity of receptor tyrosine kinase signalling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179-185.
34. Moscatelli, D. (1988). Metabolism of receptor-bound and matrix-bound basic fibroblast growth factor by bovine capillary endothelial cells. J. Cell Biol. 107, 753-759.
35. Moscatelli, D. (1992). Basic fibroblast growth factor (bFGF) dissociates rapidly from heparan sulfates but slowly from receptors. J. Biol. Chem. 267, 25803-25809
36. Moscatelli, D., Presta, M., Joseph-Silverstein, J., and Rifkin, D.B. (1986). Purification of a factor from human placenta that stimulates capillary endothelial cell protease production, DNA synthesis and migration. Proc. Natl. Acad. Sci. USA 83, 2091-2095.
37. Nakanishi, Y., Kihara, K., Mizuno, K., Masamune, Y., Yoshitake, Y., and Nishikawa, K. (1992). Direct effect of basic fibroblast growth factor on gene transcription in a cell-free system. Proc. Natl. Acad. Sci. USA 59, 5216-5220.
38. New, R.R.C. (ed.) (1990a). Preparation of liposomes. In: Liposomes: A Practical Approach, New York: Oxford University Press, 33-104.
39. New, R.R.C. (ed.) (1990b). Characterization of liposomes. In: Liposomes: A Practical Approach, New York: Oxford University Press, 105-161.
40. New, R.R.C., Black, C.D.V., Parker, R.J., Puri, A., and Scherphof, G.L. (1990). Liposomes in biological systems. In: Liposomes: A Practical Approach, ed. R.R.C. New, New York: Oxford University Press, 221-252.
41. Partanen, J., Mäkelä, T.P., Eerola, E., Korhonen, J., Hirvonen, H., Claesson-Welsh, L., and Alitalo, K. (1991). FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. EMBO J. 10, 1347-1354.
42. Pawson, T., and Schlessinger, J. (1993). SH2 and SH3 domains. Curr. Biol. 3, 434-442.
43. Pepper, M.S., and Meda, P. (1992). Basic FGF increases junctional communication and connexin 43 expression in microvascular endothelial cells. J. Cell. Physiol. 153, 196-205.
44. r 18,000 basic fibroblast growth factor: site-directed mutagenesis of a putative nuclear translocation sequence. Growth Factors 9, 269-278.
45. Presta, M., Maier, J.A.M , and Ragnotti, G. (1989). The mitogenic signaling pathway but not the plasminogen activator-inducing pathway of basic fibroblast growth factor is mediated through protein kinase C in fetal bovine aortic endothelial cells. J. Cell Biol. 109, 1877-1884.
46. Presta, M., Maier, J.A.M., Rusnati, M., Moscatelli, D., and Ragnotti, G. (1988). Modulation of plasminogen activator activity in human endometrial adenocarcinoma cells by basic fibroblast growth factor and transforming growth factor β. Cancer Res. 48, 6384-6389.
47. Presta, M., Moscatelli, D., Joseph-Silverstein, J., and Rifkin, D.B. (1986). Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration. Mol. Cell. Biol. 6, 4060-4066.
48. Presta, M., Statuto, M., Isacchi, A., Caccia, P., Pozzi, A., Gualandris, A , Rusnati, M., Bergonzoni, L., and Sarmientos, P. (1992). Structure-function relationship of basic fibroblast growth factor: site-directed mutagenesis of a putative heparin-binding and receptor-binding region. Biochem. Biophys. Res. Commun. 185, 1098-1107.
49. Presta, M., Tiberio, L., Rusnati, M., Dell'Era, P., and Ragnotti, G. (1991). Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. Cell Regul. 2, 719-726.
50. Roghani, M., and Moscatelli, D. (1992). Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms. J. Biol. Chem. 267, 22156-22162.
51. Rusnati, M., Urbinati, C., and Presta, M. (1993). Internalization of basic fibroblast growth factor (FGF-2) in cultured endothelial cells: role of the low affinity heparin-like FGF-2 receptors. J. Cell. Physiol. 154, 152-161.
52. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
53. Schlessinger, J. (1994). SH2/SH3 signalling proteins. Curr. Opin. Genet. Dev. 4, 25-30.
54. Shanafelt, A.B., and Kastelein, R.A. (1992). High affinity ligand binding is not essential for granulocyte-macrophage colony-stimulating factor receptor activation. J. Biol. Chem. 267, 25466-25472.
55. Shennan, L., Stocker, K.M., Morrison, R., and Ciment, G. (1993). Basic fibroblast growth factor (bFGF) acts intracellularly to cause the transdifferentiation of avian neural crest-derived Schwann cell precursors into melanocytes. Development 118, 1313-1326.
56. Springer, B.A., Pantoliano, M.W., Barbera, F.A., Gunyuzlu, P.L., Thompson, L.D., Herblin, W.F., Rosenfeld, S.A., and Book, G.W. (1994). Identification and concerted function of two receptor binding surfaces on basic fibroblast growth factor required for mitogenesis. J. Biol. Chem. 269, 26879-26884.
57. Strassmann, G., Bertolini, D.R., and Eidelman, O. (1991). Inhibition of immune reactions in vivo by liposome-associated transforming growth factor (TGF) type a-1. Clin. Exp. Immunol. 86, 532-536.
58. Ullrich, A., and Schlessinger, J. (1990). Signal transduction by receptors with tyrosine kinase activity. Cell 61, 205-212.
59. Unson, C.G., Macdonald, D., Ray, K., Durrah, T.L., and Merrifield, R.B. (1991). Position 9 replacement analogs of glucagon uncouple biological activity and receptor binding. J. Biol. Chem. 266, 2763-2766.
60. Wang, J.-K., Gao, G., and Goldfarb, M. (1994). Fibroblast growth factor receptors have different signaling and mitogenic potentials. Mol. Cell. Biol. 14, 181-188.
61. Weiss, R.H., and Nuccitelli, P. (1992). Inhibition of tyrosine phosphorylation prevents thrombin-induced mitogenesis, but not intracellular free calcium release, in vascular smooth muscle cells. J. Biol. Chem. 267, 5608-5613.
62. Wiedlocha, A., Falnes, P.O., Madshus, I.H., Sandvig, K., and Olsnes, S. (1994). Dual mode of signal transduction by externally added acidic fibroblast growth factor. Cell 76, 1039-1051.
63. Yayon, A., Klagsbrun, M., Esko, J.D., Lader, P., and Ornitz, D.M. (1991). Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64, 841-848